MARKET

SPRO

SPRO

Spero Therapeuti
NASDAQ
0.6501
-0.0399
-5.78%
After Hours: 0.6826 +0.0325 +5.00% 17:09 05/14 EDT
OPEN
0.7000
PREV CLOSE
0.6900
HIGH
0.7000
LOW
0.6478
VOLUME
65.57K
TURNOVER
0
52 WEEK HIGH
1.690
52 WEEK LOW
0.5052
MARKET CAP
36.35M
P/E (TTM)
-0.5123
1D
5D
1M
3M
1Y
5Y
1D
Spero Therapeutics Q1 EPS $(0.25) Beats $(0.55) Estimate, Sales $5.87M Miss $11.00M Estimate
Benzinga · 1d ago
Spero Therapeutics GAAP EPS of -$0.25 beats by $0.30, revenue of $5.87M
Seeking Alpha · 1d ago
*Spero Therapeutics CEO Rajavelu Also Nominated for Election to the Bd of Directors at Spero's 2025 Annual Meeting >SPRO
Dow Jones · 1d ago
SPERO THERAPEUTICS ANNOUNCES FIRST QUARTER 2025 OPERATING RESULTS AND PROVIDES A BUSINESS UPDATE
Reuters · 1d ago
Press Release: Spero Therapeutics Announces First -2-
Dow Jones · 1d ago
Press Release: Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
Dow Jones · 1d ago
*Spero Therapeutics 1Q Loss/Shr 25c >SPRO
Dow Jones · 1d ago
*Spero Therapeutics 1Q Rev $5.87M >SPRO
Dow Jones · 1d ago
More
About SPRO
More
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.
Recently
Symbol
Price
%Change

Webull offers Spero Therapeutics Inc stock information, including NASDAQ: SPRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRO stock methods without spending real money on the virtual paper trading platform.